A multimodal treatment of carbon ions irradiation, miRNA-34 and mTOR inhibitor specifically control high-grade chondrosarcoma cancer stem cells

Radiother Oncol. 2020 Sep:150:253-261. doi: 10.1016/j.radonc.2020.07.034. Epub 2020 Jul 24.

Abstract

Background and purpose: High-grade chondrosarcomas are chemo- and radio-resistant cartilage-forming tumors of bone that often relapse and metastase. Thus, new therapeutic strategies are urgently needed.

Material and methods: Chondrosarcoma cells (CH-2879) were exposed to carbon-ion irradiation, combined with miR-34 mimic and/or rapamycin administration. The effects of treatment on cancer stem cells, stemness-associated phenotype, radioresistance and tumor-initiating properties were evaluated.

Results: We show that high-grade chondrosarcoma cells contain a population of radioresistant cancer stem cells that can be targeted by a combination of carbon-ion therapy, miR-34 mimic administration and/or rapamycin treatment that triggers FOXO3 and miR-34 over-expression. mTOR inhibition by rapamycin triggered FOXO3 and miR-34, leading to KLF4 repression.

Conclusion: Our results show that particle therapy combined with molecular treatments effectively controls cancer stem cells and may overcome treatment resistance of high-grade chondrosarcoma.

Keywords: Cancer stem cell; Chondrosarcoma; Particle therapy; mTOR inhibitor; miR-34.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Neoplasms* / radiotherapy
  • Carbon
  • Cell Line, Tumor
  • Chondrosarcoma* / genetics
  • Chondrosarcoma* / therapy
  • Combined Modality Therapy
  • Humans
  • Ions
  • Kruppel-Like Factor 4
  • MicroRNAs* / genetics
  • Neoplasm Recurrence, Local
  • Neoplastic Stem Cells
  • TOR Serine-Threonine Kinases

Substances

  • Ions
  • KLF4 protein, human
  • Kruppel-Like Factor 4
  • MIRN34 microRNA, human
  • MicroRNAs
  • Carbon
  • MTOR protein, human
  • TOR Serine-Threonine Kinases